Skip to content

ADHEPTA Study: Adherence Questionnaire in Hepatitis C

Development and Validation of a Questionnaire Measuring Treatment Adherence in Patients With Hepatitis C

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00998621
Acronym
ADHEPTA
Enrollment
1120
Registered
2009-10-20
Start date
2009-10-31
Completion date
2013-01-31
Last updated
2015-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis C, Chronic, HIV Infection

Keywords

Hepatitis C, Chronic, HIV Infection, Medication Adherence, Questionnaire Design, Treatment experienced

Brief summary

Main objective: To study and validate a questionnaire measuring treatment adherence in patients with Hepatitis C virus (HCV) infection. Design of the study: Multicentric, prospective, epidemiological study in the field of usual clinical practice.

Interventions

OTHERAdherence questionnaire

Adherence questionnaire

Sponsors

Fundacion IMIM
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ambulatory patient infected by HCV according to diagnosis criteria used en usual clinical practice. * Patient no treated previously and beginning a treatment for HCV. * Patient that signed the informed consent to participate in the study. * Group A: patient with HCV monoinfection. * Group B: patient with HCV and HCV co-infection (according to diagnosis criteria used en usual clinical practice).

Exclusion criteria

* Patient that received previous treatment for HCV. * Patient that is going to participate in a clinical trial Turing the HCV treatment period. * Patient with cognitive impairment or patient unable to understand and answer the auto-administered questionnaire. * Patient unable to read or write Spanish.

Design outcomes

Primary

MeasureTime frame
Main objective of the study is the development and validation of a Questionnaire measuring treatment adherence in patients with HCV infection.2 years

Secondary

MeasureTime frame
Adherence will be measured according to 80/80/80 rule.2 years
Establish a relationship between adherence, virological response (VR) and Sustained virological response (SVR).2 years

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026